YS Biopharma (YSB) Stock Price, News & Analysis

Company Overview

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.40 to $6.82
• 52-Week Range: N/A
• Volume: 63,510 shs
• Average Volume: 172,401 shs
• Market Capitalization: $344.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 12/21/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:YSB
• Previous Symbol: NASDAQ:YS
• CUSIP: N/A
• CIK: 1946399
• Web: www.ysbiopharm.com
• Phone: 852-2155-7212
• Fax: N/A
• Employees: 773
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.26
• Current Ratio: 0.94
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: $560.76 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.14 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 93,058,000
• Free Float: N/A
• Market Cap: $344.32 million
• Optionable: Not Optionable
• Beta: 0.51